• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆蛋白与肺表面活性剂之间的相互作用:脉动气泡研究

Interactions between plasma proteins and pulmonary surfactant: pulsating bubble studies.

作者信息

Keough K M, Parsons C S, Tweeddale M G

机构信息

Department of Biochemistry, Memorial University of Newfoundland, St. John's, Canada.

出版信息

Can J Physiol Pharmacol. 1989 Jun;67(6):663-8. doi: 10.1139/y89-106.

DOI:10.1139/y89-106
PMID:2476209
Abstract

The influence of human albumin, alpha-globulin, and fibrinogen on the actions of porcine pulmonary surfactant in a pulsating bubble surfactometer has been investigated. All three proteins detracted from the ability of the surfactant to adsorb to the air-water interface. The proteins also reduced the ability of surfactant to lower the opening pressures of bubbles cycling between different sizes in suspensions of surfactant. This was equivalent to restricting the ability of the surfactant to achieve low surface tension during compression of the surface. Of the three proteins, globulin competed most effectively with surfactant during the adsorption process, and albumin competed the least effectively. The proteins also may have interfered with the processes of surface refinement, which usually yields a monolayer enriched enough in dipalmitoyl phosphatidylcholine to achieve very low surface tension (very low opening pressures in the bubbles). Of the three proteins tested, albumin was least deleterious to surface refining whereas globulin and fibrinogen appeared to be about equally detrimental to the process.

摘要

研究了人白蛋白、α-球蛋白和纤维蛋白原对脉动气泡表面张力仪中猪肺表面活性剂作用的影响。这三种蛋白质均降低了表面活性剂吸附到气-水界面的能力。这些蛋白质还降低了表面活性剂降低表面活性剂悬浮液中不同大小气泡循环时的开启压力的能力。这相当于限制了表面活性剂在表面压缩过程中达到低表面张力的能力。在这三种蛋白质中,球蛋白在吸附过程中与表面活性剂的竞争最有效,而白蛋白的竞争最无效。这些蛋白质还可能干扰了表面细化过程,表面细化通常会产生富含二棕榈酰磷脂酰胆碱的单分子层,从而实现非常低的表面张力(气泡中的开启压力非常低)。在测试的三种蛋白质中,白蛋白对表面细化的损害最小,而球蛋白和纤维蛋白原对该过程的损害似乎大致相同。

相似文献

1
Interactions between plasma proteins and pulmonary surfactant: pulsating bubble studies.血浆蛋白与肺表面活性剂之间的相互作用:脉动气泡研究
Can J Physiol Pharmacol. 1989 Jun;67(6):663-8. doi: 10.1139/y89-106.
2
Interactions between plasma proteins and pulmonary surfactant: surface balance studies.血浆蛋白与肺表面活性剂之间的相互作用:表面平衡研究
Can J Physiol Pharmacol. 1988 Sep;66(9):1166-73. doi: 10.1139/y88-192.
3
Artificial pulmonary surfactant inhibited by proteins.人工肺表面活性物质受蛋白质抑制。
J Appl Physiol (1985). 1987 Feb;62(2):429-37. doi: 10.1152/jappl.1987.62.2.429.
4
The role of palmitic acid in pulmonary surfactant: enhancement of surface activity and prevention of inhibition by blood proteins.
Biochim Biophys Acta. 1991 Sep 11;1085(2):248-56. doi: 10.1016/0005-2760(91)90101-m.
5
Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro.
Biochemistry. 1990 Sep 11;29(36):8424-9. doi: 10.1021/bi00488a032.
6
Surface activity of lipid extract surfactant in relation to film area compression and collapse.脂质提取物表面活性剂的表面活性与膜面积压缩和塌陷的关系。
J Appl Physiol (1985). 1994 Aug;77(2):974-86. doi: 10.1152/jappl.1994.77.2.974.
7
In vitro inhibition of biophysical surface properties and change in ultrastructures of exogenous pulmonary surfactant by albumin or fibrinogen.白蛋白或纤维蛋白原对外源性肺表面活性物质生物物理表面特性的体外抑制及超微结构变化
J Korean Med Sci. 1998 Apr;13(2):123-30. doi: 10.3346/jkms.1998.13.2.123.
8
Synchronized changing of transinterface pressure, bubble radius and surface tension: a unique feature of lung surfactant.跨界面压力、气泡半径和表面张力的同步变化:肺表面活性剂的独特特征。
Chem Phys Lipids. 1997 Sep 24;89(1):55-65. doi: 10.1016/s0009-3084(97)00063-7.
9
Pulmonary surfactant.肺表面活性物质
Can J Biochem Cell Biol. 1984 Nov;62(11):1121-33. doi: 10.1139/o84-146.
10
Biophysical inhibition of synthetic lung surfactants.合成肺表面活性剂的生物物理抑制作用。
Chem Phys Lipids. 1990 Feb;52(3-4):243-50. doi: 10.1016/0009-3084(90)90120-g.

引用本文的文献

1
The Synthetic Surfactant CHF5633 Restores Lung Function and Lung Architecture in Severe Acute Respiratory Distress Syndrome in Adult Rabbits.合成表面活性剂 CHF5633 可恢复成年兔严重急性呼吸窘迫综合征的肺功能和肺结构。
Lung. 2024 Jun;202(3):299-315. doi: 10.1007/s00408-024-00689-z. Epub 2024 Apr 29.
2
Surfactant phospholipid composition of gastric aspirate samples differs between male and female very preterm infants.胃抽吸样本中表面活性剂磷脂成分在男性和女性极早产儿之间存在差异。
Pediatr Res. 2017 Nov;82(5):839-849. doi: 10.1038/pr.2017.147. Epub 2017 Aug 2.
3
Surfactant therapy for acute lung injury and acute respiratory distress syndrome.
表面活性物质治疗急性肺损伤和急性呼吸窘迫综合征。
Crit Care Clin. 2011 Jul;27(3):525-59. doi: 10.1016/j.ccc.2011.04.005.
4
The pulmonary surfactant: impact of tobacco smoke and related compounds on surfactant and lung development.肺表面活性物质:烟草烟雾及相关化合物对表面活性物质和肺发育的影响
Tob Induc Dis. 2004 Mar 15;2(1):3-25. doi: 10.1186/1617-9625-2-1-3.
5
Surfactant for pediatric acute lung injury.用于小儿急性肺损伤的表面活性剂
Pediatr Clin North Am. 2008 Jun;55(3):545-75, ix. doi: 10.1016/j.pcl.2008.02.016.
6
Function and inhibition sensitivity of the N-terminal segment of surfactant protein B (SP-B1-25) in preterm rabbits.表面活性蛋白B的N端片段(SP-B1-25)在早产兔中的功能及抑制敏感性
Thorax. 2001 Nov;56(11):871-6. doi: 10.1136/thorax.56.11.871.
7
Pulmonary inflammation disrupts surfactant function during Pneumocystis carinii pneumonia.卡氏肺孢子虫肺炎期间,肺部炎症会破坏表面活性物质的功能。
Infect Immun. 2001 Feb;69(2):758-64. doi: 10.1128/IAI.69.2.758-764.2001.
8
Ozone stress initiates acute perturbations of secreted surfactant membranes.臭氧胁迫引发分泌型表面活性剂膜的急性扰动。
Am J Pathol. 1991 Apr;138(4):847-57.